Showing results (301-310 of 327) with videos related to
Sort By:
Pageof 33
Parkinsonism & Related Disorders|March 15, 2001
The long-term safety and efficacy of pramipexole in advanced Parkinson's diseaseW J. Weiner, S A. Factor, J Jankovic, et al.Neurology|October 26, 1999
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystoniaM F Brin, M F Lew, C H Adler, et al.Neurology|January 15, 2003
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PDJ G Nutt, K J Burchiel, C L Comella, et al.Neurology|January 1, 1997
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic studyI Litvan, Y Agid, C Goetz, et al.Parkinsonism & Related Disorders|May 20, 2019
McLeod syndrome: Five new pedigrees with novel mutationsJ Weaver, H Sarva, D Barone, et al.Neurology|December 28, 2006
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystoniaJ Jankovic, C Hunter, B Z Dolimbek, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophyI Litvan, V Booth, G K Wenning, et al.Archives of Neurology|August 1, 1997
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic studyI Litvan, C G Goetz, J Jankovic, et al.Neurology|July 1, 1996
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshopI Litvan, Y Agid, D Calne, et al.Neurology|April 1, 1996
Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)I Litvan, Y Agid, J Jankovic, et al.Pageof 33